中恒集团: 广西梧州中恒集团股份有限公司关于控股子公司投资的产业投资基金延长存续期限暨完成工商登记的公告

Group 1 - The core point of the announcement is the extension of the operational period of the investment fund "Sai Fu Health" by two years, now set to expire on July 26, 2027, due to incomplete project exits [1][2] - The fund was established in 2018 by Chongqing Laimei Pharmaceutical Co., Ltd., a subsidiary of the company, in partnership with Sai Fu Capital and Guangdong Lihe Investment Holdings [1] - The extension is in line with the fund's operational needs and does not affect the existing rights of Laimei Pharmaceutical, nor does it significantly impact the company's financial or operational status [2] Group 2 - The announcement confirms that the extension of the fund's duration is necessary for the normal operation and project exit of the fund, ensuring the interests of all partners are maintained [2] - The company will continue to monitor the developments of Sai Fu Health and comply with relevant legal and regulatory requirements for timely information disclosure [2]